Discover 101 paid clinical trials in Alaska. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.
Alaska offers a variety of research opportunities for healthy volunteers, as well as for individuals looking for trials for specific health conditions. Major research sites in Anchorage, Fairbanks, and Juneau are recruiting participants, providing access to innovative treatments and advanced medical care.
Filter
1
Filter results
Results: 101
Active & Responsive
A Study to Evaluate the Efficacy and Safety of Golcadomide in Combination With Rituximab in Participants With Newly Diagnosed Advanced Stage Follicular Lymphoma
for
Lymphoma, Follicular
Location: Anchorage AK, Seattle WA, San Francisco CA,
Sponsor: Celgene
Sex: All
Age: 18+
Code: NCT06425302
Phase2, Recruiting
Active & Responsive
Safety, Effectiveness, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer
for
Non-small Cell Lung Cancer
Location: Anchorage AK, Hastings NE, Cedar Rapids IA,
Sponsor: BioNTech SE
Sex: All
Age: 18+
Code: NCT06712316
Phase2, Phase3, Recruiting
Active & Responsive
Study to Compare the Effectiveness and Safety of Golcadomide Plus R-CHOP vs Placebo Plus R-CHOP in Participants With Previously Untreated High-risk Large B-cell Lymphoma
A Study of Zilovertamab Vedotin (MK-2140) as Monotherapy and in Combination in Participants With Aggressive and Indolent B-cell Malignancies (MK-2140-006)
A Prospective Registry Study to Assess Real-world Patient Characteristics, Treatment Patterns, and Longitudinal Outcomes in Patients Receiving Mavacamten and Other Treatments for Symptomatic Obstructive Hypertrophic Cardiomyopathy (Obstructive-HCM)
for
Obstructive Hypertrophic Cardiomyopathy
Location: Anchorage AK, Seattle WA, San Francisco CA,
Sponsor: Bristol-Myers Squibb
Sex: All
Age: 18+
Code: NCT05489705
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Active & Responsive
MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles
for
Breast Cancer
Location: Anchorage AK, Mount Vernon WA, Seattle WA, Portland OR,
Sponsor: Agendia
Sex: All
Age: 18+
Code: NCT03053193
Recruiting
Active & Responsive
Testing the Use of the Combination of Selumetinib and Olaparib or Selumetinib Alone Targeted Treatment for RAS Pathway Mutant Recurrent or Persistent Ovarian and Endometrial Cancers, A ComboMATCH Treatment Trial
A Study to Evaluate the Optimization of the Cytokine Release Syndrome Profile for Glofitamab in Combination With Gemcitabine Plus Oxaliplatin in Participants With Relapsed/Refractory Diffuse Large B-Cell Lymphoma